Skip to content

Integrated Parkinson Care Networks: Assessment of Economics and Socials Barriers

Integrated Parkinson Care Networks: Assessment of Economics and Socials Barriers to the Optimal Care Pathway for Parkinson Disease Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04485468
Acronym
ECOSO-ICAREPD
Enrollment
72
Registered
2020-07-24
Start date
2021-02-12
Completion date
2021-07-02
Last updated
2023-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson Disease,, Socio-economic

Brief summary

According to the latest public health report in France, Parkinson's disease (PD) affects around 160,000 patients. It is therefore essential to estimate the overall consumption of medical and non-medical resources by patients with PD in order to characterize the share of medical and non-medical care reimbursed by health insurance, the share of medical and non-medical care not reimbursed. by health insurance, as well as the share of formal and informal care in order to identify potential economic barriers to an optimal care path for patients with PD. It is also necessary to have information on the socio-economic characteristics and the place of residence of the resident in order to estimate the impact of these determinants on an optimal course of care.

Detailed description

According to the latest public health report in France, Parkinson's disease (PD) affects around 160,000 patients The coordination of the care pathway for patients with Parkinson disease has been improved since the implementation on the national territory of 7 interregional coordination centers and 25 regional expert centers in 2012. Health insurance reimburses 100% of direct medical and non-medical care as soon as patients are registered in Long-Term Condition n°16. However, we currently have little information about care that is not recognized for financial coverage by health insurance. It is therefore essential to estimate the overall consumption of medical and non-medical resources by patients with PD in order to characterize the share of medical and non-medical care reimbursed by health insurance, the share of medical and non-medical care not reimbursed. by health insurance, as well as the share of formal and informal care in order to identify potential economic barriers to an optimal care path for patients with PD. It is also necessary to have information on the socio-economic characteristics and the place of residence of the resident in order to estimate the impact of these determinants on an optimal course of care.

Interventions

OTHERQuestionnaire

The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with Parkinson's disease of any stage of severity * Patients over 18 years of age * Patients living at home * Patient consultant at the expert center Parkinson's at Toulouse University Hospital

Exclusion criteria

* Pregnant and lactating woman * Patient under guardianship, curatorship or safeguard of justice * Person who does not understand French to be able to answer the questionnaire * Patient who participated or participated in the iCare PD project

Design outcomes

Primary

MeasureTime frameDescription
Identify the economic barriers to an optimal care pathDay 0It is the collection of the number of resources consumed and the remainder to be borne by the patient as well as the number of hours of informal help that will be valued using the replacement cost approach.

Secondary

MeasureTime frameDescription
Identify and quantify the cost of the care pathway for patients with Parkinson's diseaseDay 0it is the quantification of the number of resources consumed and identification of the unit costs for each type of resources consumed.
identify socio-economic determinantsDay 0identify the socio-economic and territorial determinants that could have an impact on an optimal care path.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026